CORDIS - Forschungsergebnisse der EU
CORDIS

Use of EGF-R antagonists for the treatment of chronic infections and tumor growth

Ziel

FoxP3 expressing regulatory T-cells play an important role in the induction of peripheral tolerance and the prevention of auto-immune responses. How the functionality of regulatory T-cells is regulated at the site of inflammation remains poorly understood. We just recently discovered that the functionality of regulatory T-cells is regulated via the EGF-R that is expressed by activated regulatory T-cells. In in vitro suppression assays the presence of the EGF-like growth factor Amphiregulin significantly enhanced the suppressive capacity of regulatory T-cells and, in vivo, Amphiregulin-induced signals enabled regulatory T-cells to induce tolerance against innocuous antigens. This effect was blocked upon application of EGF-R antagonists (Zaiss et al. 2013).
Based on these findings, the objectives of this proposal are:
1.a) To determine the role of regulatory T-cells during tumor therapy; in specific during induced lymphopenia in the context of adoptive cell transfer (ACT) based tumor therapy.
1.b) To determine whether EGF-R inhibitors can suppress regulatory T-cell function such that they enhance the efficacy of ACT based tumor therapy?
2) To determine whether smallpox viruses use their virus-encoded EGF-like growth factors to enhance regulatory T-cell function, and thus as an immune escape mechanism? This will answer the question whether interference with regulatory T-cell function explains for the immune-stimulatory effect of EGF-R inhibitor treatment, during vaccinia virus infections.
3) To determine whether we can develop an EGF-R inhibitor that selectively targets regulatory T-cells, and thus keeps all other functions of the EGF-R, for example in tissue homeostasis, intact?

Taken together, this proposed project tests a novel therapeutic approach by which we expect to have hit a so far unrecognized, therapeutic “Achilles’ heel” of Tregs, i.e. via the regulation of Treg functionality by EGF-R ligands.

Aufforderung zur Vorschlagseinreichung

FP7-PEOPLE-2013-CIG
Andere Projekte für diesen Aufruf anzeigen

Koordinator

THE UNIVERSITY OF EDINBURGH
EU-Beitrag
€ 100 000,00
Adresse
OLD COLLEGE, SOUTH BRIDGE
EH8 9YL Edinburgh
Vereinigtes Königreich

Auf der Karte ansehen

Region
Scotland Eastern Scotland Edinburgh
Aktivitätstyp
Higher or Secondary Education Establishments
Kontakt Verwaltung
Angela Noble (Ms.)
Links
Gesamtkosten
Keine Daten